Kane LP - Search Results

1

TIM3 expression by leukemic and non-leukemic myeloblasts.

Roth CG, Garner K, Eyck ST, Boyiadzis M, Kane LP, Craig FE. Roth CG, et al. Among authors: kane lp. Cytometry B Clin Cytom. 2013 May;84(3):167-72. doi: 10.1002/cyto.b.21080. Epub 2013 Mar 29. Cytometry B Clin Cytom. 2013. PMID: 23554257 Free article.

2

Immune regulation by the TIM gene family.

de Souza AJ, Kane LP. de Souza AJ, et al. Among authors: kane lp. Immunol Res. 2006;36(1-3):147-55. doi: 10.1385/IR:36:1:147. Immunol Res. 2006. PMID: 17337775 Review.

3

Novel Effector Phenotype of Tim-3⁺ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients.

Liu Z, McMichael EL, Shayan G, Li J, Chen K, Srivastava R, Kane LP, Lu B, Ferris RL. Liu Z, et al. Among authors: kane lp. Clin Cancer Res. 2018 Sep 15;24(18):4529-4538. doi: 10.1158/1078-0432.CCR-17-1350. Epub 2018 Apr 30. Clin Cancer Res. 2018. PMID: 29712685 Free PMC article.

4

TIM-3-Expressing Mast Cells Are Present in Chronic Rhinosinusitis with Nasal Polyps.

Corredera E, Phong BL, Moore JA, Kane LP, Lee SE. Corredera E, et al. Among authors: kane lp. Otolaryngol Head Neck Surg. 2018 Sep;159(3):581-586. doi: 10.1177/0194599818774560. Epub 2018 May 15. Otolaryngol Head Neck Surg. 2018. PMID: 29759032

5

Differential Expression of Immune Checkpoint Molecules on CD8⁺ T Cells Specific for Immunodominant and Subdominant Herpes Simplex Virus 1 Epitopes.

Carroll KL, Avery L, Treat BR, Kane LP, Kinchington PR, Hendricks RL, St Leger AJ. Carroll KL, et al. Among authors: kane lp. J Virol. 2020 Jan 6;94(2):e01132-19. doi: 10.1128/JVI.01132-19. Print 2020 Jan 6. J Virol. 2020. PMID: 31645447 Free PMC article.

6

Association of Mast Cell Burden and TIM-3 Expression with Recalcitrant Chronic Rhinosinusitis with Nasal Polyps.

Belsky MA, Corredera E, Banerjee H, Moore J, Wang L, Kane LP, Lee SE. Belsky MA, et al. Among authors: kane lp. Ann Otol Rhinol Laryngol. 2021 Sep;130(9):1069-1077. doi: 10.1177/0003489421995038. Epub 2021 Feb 12. Ann Otol Rhinol Laryngol. 2021. PMID: 33576238 Free PMC article.

7

Regulation of Tim-3 function by binding to phosphatidylserine.

Kane LP. Kane LP. Biochem J. 2021 Nov 26;478(22):3999-4004. doi: 10.1042/BCJ20210652. Biochem J. 2021. PMID: 34813649

8

Tim-3 mediates T cell trogocytosis to limit antitumor immunity.

Pagliano O, Morrison RM, Chauvin JM, Banerjee H, Davar D, Ding Q, Tanegashima T, Gao W, Chakka SR, DeBlasio R, Lowin A, Kara K, Ka M, Zidi B, Amin R, Raphael I, Zhang S, Watkins SC, Sander C, Kirkwood JM, Bosenberg M, Anderson AC, Kuchroo VK, Kane LP, Korman AJ, Rajpal A, West SM, Han M, Bee C, Deng X, Schebye XM, Strop P, Zarour HM. Pagliano O, et al. Among authors: kane lp. J Clin Invest. 2022 May 2;132(9):e152864. doi: 10.1172/JCI152864. J Clin Invest. 2022. PMID: 35316223 Free PMC article.

9

Increased PD-1⁺ and TIM-3⁺ TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients.

Jie HB, Srivastava RM, Argiris A, Bauman JE, Kane LP, Ferris RL. Jie HB, et al. Among authors: kane lp. Cancer Immunol Res. 2017 May;5(5):408-416. doi: 10.1158/2326-6066.CIR-16-0333. Epub 2017 Apr 13. Cancer Immunol Res. 2017. PMID: 28408386 Free PMC article. Clinical Trial.

10

T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase.

de Souza AJ, Oak JS, Jordanhazy R, DeKruyff RH, Fruman DA, Kane LP. de Souza AJ, et al. Among authors: kane lp. J Immunol. 2008 May 15;180(10):6518-26. doi: 10.4049/jimmunol.180.10.6518. J Immunol. 2008. PMID: 18453570 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page